Uncategorized

Branded tests designed to predict if breast cancer will come back vary in accuracy, according to a new study. Four tests differed in their ability to predict if breast cancer would return 0-10 or 5-10 years after diagnosis. Lead researcher Dr Ivana Sestak said the results could help doctors decide on the best test for their patients.  “If a woman is deemed high risk of recurrence by any test, the benefit of chemotherapy is greatest. In contrast, if a woman is deemed low risk then endocrine therapy alone will be sufficient and patients could forego chemotherapy and its side effects,” she said.

 

See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2018-02-16-breast-cancer-relapse-tests-vary-in-accuracy